Main Menu

News and features 

Read the latest stories about our world-leading research, science, fundraising and philanthropy

To find out more, you can contact our media team, follow us on social media or visit our press release archive.


Sign up for our newsletters


News

ICR welcomes MHRA approval of 'search and destroy' prostate cancer treatment 11
Aug
2022

The Institute of Cancer Research, London, strongly welcomes the news that 177Lu-PSMA-617, a highly targeted radioactive drug, has been approved by the medicines regulator, the MHRA, for some patients with advanced prostate cancer. Find out more

Skin cancer cells harness nerve cell gene to drill through and invade new tissues 08
Aug
2022

Melanoma skin cancer cells harness a gene usually used by growing nerves to escape from their immediate area and spread through tissues, new research has found. Find out more

All patients’ cancers should be genetically profiled to improve care, say leading health experts 08
Aug
2022

The NHS should offer all cancer patients genetic profiling of their cancers at diagnosis and during treatment to shape care and track how the disease evolves, a consensus group of leading experts has concluded. Find out more

See all news articles

Features

PhD student Rose Foster wins ICR Science and Medical Imaging Competition 21
Jul
2022

PhD student Rose Foster in the Prostate and Bladder Cancer Team in the Division of Radiotherapy and Imaging has won the ICR Science and Medical Imaging Competition 2022 for her image of a fluorescent image of bladder tumour tissue. Find out more

Our research impact: breast cancer radiotherapy 12
May
2022

To mark our outstanding success in REF2021, Gege Li spoke to two of our researchers here at the ICR who have played central roles in improving the use of radiotherapy in the treatment of breast cancer – transforming the lives of many thousands of patients. Find out more

Our research impact: prostate cancer radiotherapy 12
May
2022

To mark our outstanding success in REF2021, Gege Li spoke to several of our researchers here at the ICR who have pioneered improved use of radiotherapy in the treatment of prostate cancer. Find out more

See all feature articles